Alyeska Investment Group’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-100,000
Closed -$1.68M 677
2024
Q2
$1.68M Buy
+100,000
New +$1.68M 0.01% 409
2017
Q3
Sell
-50,000
Closed -$903K 509
2017
Q2
$903K Buy
+50,000
New +$903K 0.01% 397